Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Immunology, Immunopathogenesis and Immunotherapeutics of Covid-19; an Overview Publisher Pubmed



Mohamed Khosroshahi L1 ; Rokni M1 ; Mokhtari T2, 3 ; Noorbakhsh F1, 4
Authors

Source: International Immunopharmacology Published:2021


Abstract

Coronavirus disease 2019 (COVID-19) infection which is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to a “public health emergency of international concern” (PHEIC). The infection is highly contagious, has a high mortality rate, and its pathophysiology remains poorly understood. Pulmonary inflammation with substantial lung damage together with generalized immune dysregulation are major components of COVID-19 pathogenesis. The former component, lung damage, seems to be at least in part a consequence of immune dysregulation. Indeed, studies have revealed that immune alteration is not merely an association, as it might occur in systemic infections, but, very likely, the core pathogenic element of COVID-19. In addition, precise management of immune response in COVID-19, i.e. enhancing anti-viral immunity while inhibiting systemic inflammation, may be key to successful treatment. Herein, we have reviewed current evidence related to different aspects of COVID-19 immunology, including innate and adaptive immune responses against the virus and mechanisms of virus-induced immune dysregulation. Considering that current antiviral therapies are chiefly experimental, strategies to do immunotherapy for the management of disease have also been reviewed. Understanding immunology of COVID-19 is important in developing effective therapies as well as diagnostic, and prophylactic strategies for this disease. © 2021 Elsevier B.V.
Other Related Docs
4. Immune-Based Therapy for Covid-19, Advances in Experimental Medicine and Biology (2021)
9. Pharmacological Treatments of Covid-19, Pharmacological Reports (2020)
10. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)
13. Potential Antiviral Immune Response Against Covid-19: Lessons Learned From Sars-Cov, Advances in Experimental Medicine and Biology (2021)